Your Search Returned 216 tagged news reports
Rite Aid believe the stock will underperform the S&P 500 going forward. Hunter , touched on the stock's seemingly unsustainable price run: Rite Aid has rallied this year after it surprised investors and analysts with its first profit in several years.
The company announced its first-quarter results after the market close on Monday, and shares were up more than 1% in after-hours trading. Here's what you need to know about Express Scripts' first quarter...Express Scripts reported first-quarter net
Express Scripts says its first-quarter earnings jumped 39 percent compared to last year, when charges tied to its acquisition of competitor Medco Health Solutions hurt the largest U.S. pharmacy benefit manager's performance. The acquisition more than
Williams of the Health business blog Pharmaceutical Benefits Manager (PBM) Express Scripts released a report claiming that more than $400B in annual pharmacy expenditures are wasted and that the greatest waste occurs in the poorest states, i.e., the
Jake is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited...The second quarter of the $46 billion market cap retail pharmacy's fiscal year ended in February, with Walgreen
are the two leaders in the pharma industry, however, the questions is, which is the better investment? A quick look at the valuation and the continued success of CVS' market share gains could mean that CVS is your best bet in the pharma industry.
The company has received an unsolicited "mini-tender" offer for a block of its shares from TRC Capital, which has offered to buy up to 2 million shares of the company, roughly 0.24% of the outstanding amount, at $55.75 apiece. Express Scripts is
Walgreen Co.'s revenue from established stores climbed slightly last month, as Easter Sunday's earlier appearance compared to last year both helped and hurt the performance of the nation's largest drugstore chain. The Deerfield company said Wednesday
announced it wouldn't renew its contract with the drug distributor...Walgreen was Cardinal's second largest customer, accounting for 21% of fiscal 2012 revenues...Express Scripts had been Cardinal's third largest customer, but it decided to go
This followed a lengthy probe in to how the fund invested money and the tens of millions of dollars in fees one executive took from Wall Street for steering business...These were the same two individuals who met with former Medco ceo David Snow as